Short Term Outcome of Differentiated Thyroid Cancer Patients with Detectable Serum Thyroglobulin after Initial Treatment Receiving a Second 131-IODINE Therapy

被引：0
|
作者：
Pace, L. [1 ]
Klain, M. [1 ]
Soricelli, A. [2 ]
Albanese, C. [1 ]
Salvatore, B. [1 ]
Storto, G. [3 ]
Salvatore, M. [1 ]
机构：
[1] Univ Naples Federico II, Naples, Italy
[2] Univ Parthenope, Naples, Italy
[3] CNR, IBB, I-80125 Naples, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2005年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 50 条
  • [41] Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer: A study using the micronucleus test
    Gutiérrez, Sara
    Carbonell, Elisabet
    Galofré, Pere
    Creus, Amadeu
    Marcos, Ricardo
    European Journal of Nuclear Medicine and Molecular Imaging, 1999, 26 (12): : 1589 - 1596
  • [42] Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer -: A study using the micronucleus test
    Gutiérrez, S
    Carbonell, E
    Galofré, P
    Creus, A
    Marcos, R
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (12) : 1589 - 1596
  • [43] Pathological evaluation of differentiated thyroid cancer in patients with positive serum thyroglobulin and negative iodine scan
    Ansari, M.
    Babaei, A. A.
    Shafiei, B.
    Javadi, H.
    Assadi, M.
    Nabipour, I.
    Asli, I. N.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (13) : 1925 - 1929
  • [44] Can we safely reduce the administration of 131-iodine in patients with differentiated thyroid cancer? – experience of the Brugmann hospital in Brussels
    Laura Iconaru
    Felicia Baleanu
    Georgiana Taujan
    Ruth Duttmann
    Linda Spinato
    Rafik Karmali
    Pierre Bergmann
    Anne-Sophie Hambye
    Thyroid Research, 13
  • [45] Can we safely reduce the administration of 131-iodine in patients with differentiated thyroid cancer? - experience of the Brugmann hospital in Brussels
    Iconaru, Laura
    Baleanu, Felicia
    Taujan, Georgiana
    Duttmann, Ruth
    Spinato, Linda
    Karmali, Rafik
    Bergmann, Pierre
    Hambye, Anne-Sophie
    THYROID RESEARCH, 2020, 13 (01)
  • [46] Evaluation of iodine-131 therapy for differentiated thyroid carcinoma patients with elevated thyroglobulin and negative iodine-131 whole body scan.
    Tian, R
    Qin, SW
    Kuang, RA
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 334P - 334P
  • [47] Stimulated thyroglobulin and diagnostic 131-iodine whole-body scan as a predictor of distant metastasis and association with response to treatment in pediatric thyroid cancer patients
    Alves-Junior, Paulo Alonso Garcia
    Barreto, Marise Codeco de Andrade
    de Andrade, Fernanda Accioly
    Bulzico, Daniel Alves
    Corbo, Rossana
    Vaisman, Fernanda
    ENDOCRINE, 2024, 84 (03) : 1081 - 1087
  • [48] Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment - initial experience
    Werner, Rudolf
    Lckerath, Katharina
    Higuchi, Takahiro
    Haenscheid, Heribert
    Reiners, Christoph
    Lapa, Constantin
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [49] Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
    R. A. Werner
    K. Lückerath
    J. S. Schmid
    T. Higuchi
    M. C. Kreissl
    I. Grelle
    C. Reiners
    A. K. Buck
    C. Lapa
    Scientific Reports, 6
  • [50] Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment - initial experience
    Werner, R. A.
    Lueckerath, K.
    Schmid, J. S.
    Higuchi, T.
    Kreissl, M. C.
    Grelle, I.
    Reiners, C.
    Buck, A. K.
    Lapa, C.
    SCIENTIFIC REPORTS, 2016, 6
12345